These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 35723633)

  • 21. Neurofibromatosis type 1 gene as a mutational target in a mismatch repair-deficient cell type.
    Wang Q; Montmain G; Ruano E; Upadhyaya M; Dudley S; Liskay RM; Thibodeau SN; Puisieux A
    Hum Genet; 2003 Feb; 112(2):117-23. PubMed ID: 12522551
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Metaplastic breast cancer in a patient with neurofibromatosis type 1 and somatic loss of heterozygosity.
    Suarez-Kelly LP; Akagi K; Reeser JW; Samorodnitsky E; Reeder M; Smith A; Roychowdhury S; Symer DE; Carson WE
    Cold Spring Harb Mol Case Stud; 2018 Apr; 4(2):. PubMed ID: 29449315
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Next-generation panel sequencing identifies
    Gieldon L; Masjkur JR; Richter S; Därr R; Lahera M; Aust D; Zeugner S; Rump A; Hackmann K; Tzschach A; Januszewicz A; Prejbisz A; Eisenhofer G; Schrock E; Robledo M; Klink B
    Eur J Endocrinol; 2018 Feb; 178(2):K1-K9. PubMed ID: 29158289
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Breast cancer risk in neurofibromatosis type 1 is a function of the type of
    Frayling IM; Mautner VF; van Minkelen R; Kallionpaa RA; Aktaş S; Baralle D; Ben-Shachar S; Callaway A; Cox H; Eccles DM; Ferkal S; LaDuca H; Lázaro C; Rogers MT; Stuenkel AJ; Summerour P; Varan A; Yap YS; Zehou O; Peltonen J; Evans DG; Wolkenstein P; Upadhyaya M
    J Med Genet; 2019 Apr; 56(4):209-219. PubMed ID: 30530636
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Single-sperm analysis for haplotype construction of de-novo paternal mutations: application to PGD for neurofibromatosis type 1.
    Altarescu G; Brooks B; Kaplan Y; Eldar-Geva T; Margalioth EJ; Levy-Lahad E; Renbaum P
    Hum Reprod; 2006 Aug; 21(8):2047-51. PubMed ID: 16740526
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The mutational spectrum of the NF1 gene in neurofibromatosis type I patients from UAE.
    Ben-Salem S; Al-Shamsi AM; Ali BR; Al-Gazali L
    Childs Nerv Syst; 2014 Jul; 30(7):1183-9. PubMed ID: 24413922
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of somatic mutations in tibial pseudarthrosis samples in neurofibromatosis type 1.
    Sant DW; Margraf RL; Stevenson DA; Grossmann AH; Viskochil DH; Hanson H; Everitt MD; Rios JJ; Elefteriou F; Hennessey T; Mao R
    J Med Genet; 2015 Apr; 52(4):256-61. PubMed ID: 25612910
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Screening in silico predicted remotely acting NF1 gene regulatory elements for mutations in patients with neurofibromatosis type 1.
    Hamby SE; Reviriego P; Cooper DN; Upadhyaya M; Chuzhanova N
    Hum Genomics; 2013 Aug; 7(1):18. PubMed ID: 23947441
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A RASopathy gene commonly mutated in cancer: the neurofibromatosis type 1 tumour suppressor.
    Ratner N; Miller SJ
    Nat Rev Cancer; 2015 May; 15(5):290-301. PubMed ID: 25877329
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A clinical and genetic overview of 18 years neurofibromatosis type 1 molecular diagnostics in the Netherlands.
    van Minkelen R; van Bever Y; Kromosoeto JN; Withagen-Hermans CJ; Nieuwlaat A; Halley DJ; van den Ouweland AM
    Clin Genet; 2014 Apr; 85(4):318-27. PubMed ID: 23656349
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A highly sensitive genetic protocol to detect NF1 mutations.
    Valero MC; Martín Y; Hernández-Imaz E; Marina Hernández A; Meleán G; Valero AM; Javier Rodríguez-Álvarez F; Tellería D; Hernández-Chico C
    J Mol Diagn; 2011 Mar; 13(2):113-22. PubMed ID: 21354044
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Two independent de novo mutations as a cause for neurofibromatosis type 1 and Noonan syndrome in a single family.
    Pasmant E; Amiel J; Rodriguez D; Vidaud M; Vidaud D; Parfait B
    Am J Med Genet A; 2012 Sep; 158A(9):2290-1. PubMed ID: 22847776
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neurofibromatosis type 1-associated tumours: their somatic mutational spectrum and pathogenesis.
    Laycock-van Spyk S; Thomas N; Cooper DN; Upadhyaya M
    Hum Genomics; 2011 Oct; 5(6):623-90. PubMed ID: 22155606
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expanding the Noonan spectrum/RASopathy NGS panel: Benefits of adding NF1 and SPRED1.
    Witkowski L; Dillon MW; Murphy E; S Lebo M; Mason-Suares H
    Mol Genet Genomic Med; 2020 Apr; 8(4):e1180. PubMed ID: 32107864
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The NF1 somatic mutational landscape in sporadic human cancers.
    Philpott C; Tovell H; Frayling IM; Cooper DN; Upadhyaya M
    Hum Genomics; 2017 Jun; 11(1):13. PubMed ID: 28637487
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Screening for mutation site on the type I neurofibromatosis gene in a family.
    Lv M; Zhao W; Yan L; Chen L; Cui K; Gao J; Yu F; Li S
    Childs Nerv Syst; 2012 May; 28(5):721-7. PubMed ID: 22207399
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neurofibromatosis type 1 due to germ-line mosaicism in a clinically normal father.
    Lázaro C; Ravella A; Gaona A; Volpini V; Estivill X
    N Engl J Med; 1994 Nov; 331(21):1403-7. PubMed ID: 7969279
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Example of somatic mosaicism in a series of de novo neurofibromatosis type 1 cases due to a maternally derived deletion.
    Ainsworth PJ; Chakraborty PK; Weksberg R
    Hum Mutat; 1997; 9(5):452-7. PubMed ID: 9143926
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Contribution of whole genome sequencing in the molecular diagnosis of mosaic partial deletion of the NF1 gene in neurofibromatosis type 1.
    Pacot L; Pelletier V; Chansavang A; Briand-Suleau A; Burin des Roziers C; Coustier A; Maillard T; Vaucouleur N; Orhant L; Barbance C; Lermine A; Hamzaoui N; Hadjadj D; Laurendeau I; El Khattabi L; Nectoux J; Vidaud M; Parfait B; Dollfus H; Pasmant E; Vidaud D
    Hum Genet; 2023 Jan; 142(1):1-9. PubMed ID: 35941319
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A variable combination of features of Noonan syndrome and neurofibromatosis type I are caused by mutations in the NF1 gene.
    Hüffmeier U; Zenker M; Hoyer J; Fahsold R; Rauch A
    Am J Med Genet A; 2006 Dec; 140(24):2749-56. PubMed ID: 17103458
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.